NOSTRILLA- oxymetazoline hydrochloride spray, metered 
Insight Pharmaceuticals LLC

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Nostrilla

Drug Facts

Active Ingredient (per spray)

oxymetazoline hydrochloride 0.05%

Purpose

Nasal decongestant

Uses

Warnings

Ask a doctor before use if you have

  • heart disease
  • thyroid disease
  • high blood pressure
  • diabetes
  • trouble urinating due to an enlarged prostate gland

When using this product

  • do not exceed recommended dosage
  • temporary discomfort such as burning, stinging, sneezing, or an increase in nasal discharge may occur
  • do not use for more than 3 days. Use only as directed. Frequent or prolonged use may cause nasal congestion to recur or worsen.
  • use of this container by more than one person may spread infection

Stop use and ask a doctor if

symptoms persist

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

Directions

Squeeze and unscrew to remove the protective cap. Align rail grooves and prime pump by depressing it firmly several times (see illustration on side). Hold bottle with thumb at base and nozzle between first and second fingers. With head upright, insert nozzle into nostril. Depress pump two or three times, all the way down, and sniff deeply.

Other Information

Inactive ingredients

benzalkonium chloride, edetate disodium, glycerin, polyethylene glycol, povidone, propylene glycol, sodium phosphate dibasic, sodium phosphate monobasic, water

Questions or comments?

1-800-344-7239

PRINCIPAL DISPLAY PANEL

Nōstrilla® 
Oxymetazoline HCl Nasal Solution
NASAL DECONGESTANT
1/2 FL. OZ (15 mL)

Nōstrilla® 
Oxymetazoline HCl Nasal Solution 
NASAL DECONGESTANT
1/2 FL. OZ  (15 mL)

NOSTRILLA 
oxymetazoline hydrochloride spray, metered
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:63736-730
Route of AdministrationNASAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
OXYMETAZOLINE HYDROCHLORIDE (UNII: K89MJ0S5VY) (OXYMETAZOLINE - UNII:8VLN5B44ZY) OXYMETAZOLINE HYDROCHLORIDE0.05 mg  in 100 mL
Inactive Ingredients
Ingredient NameStrength
BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7)  
EDETATE DISODIUM (UNII: 7FLD91C86K)  
GLYCERIN (UNII: PDC6A3C0OX)  
POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  
POVIDONE (UNII: FZ989GH94E)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS (UNII: 22ADO53M6F)  
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS (UNII: KH7I04HPUU)  
WATER (UNII: 059QF0KO0R)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:63736-730-011 in 1 CARTON06/08/2009
115 mL in 1 BOTTLE, SPRAY; Type 2: Prefilled Drug Delivery Device/System (syringe, patch, etc.)
2NDC:63736-730-021 in 1 CARTON06/08/2009
222.5 mL in 1 BOTTLE, SPRAY; Type 2: Prefilled Drug Delivery Device/System (syringe, patch, etc.)
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart34106/08/2009
Labeler - Insight Pharmaceuticals LLC (055665422)

Revised: 12/2022
Document Id: 73e21c3c-bbd6-4f12-beb4-262a31eacdd3
Set id: 86217847-8e2b-48cc-b289-4987fd3aa7c3
Version: 6
Effective Time: 20221221
 
Insight Pharmaceuticals LLC